Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

8.1%

3 terminated/withdrawn out of 37 trials

Success Rate

84.2%

-2.3% vs industry average

Late-Stage Pipeline

16%

6 trials in Phase 3/4

Results Transparency

0%

0 of 16 completed trials have results

Key Signals

5 recruiting

Enrollment Performance

Analytics

N/A
25(69.4%)
Phase 3
4(11.1%)
Phase 2
3(8.3%)
Phase 1
2(5.6%)
Phase 4
2(5.6%)
36Total
N/A(25)
Phase 3(4)
Phase 2(3)
Phase 1(2)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (37)

Showing 20 of 37 trials
NCT07520708Not ApplicableActive Not Recruiting

Performance and Safety of HyalganBio® Intra-Articular Injections as Add-On to Physical Exercise for Symptomatic Glenohumeral Osteoarthritis

Role: lead

NCT06190028Not ApplicableTerminated

Evaluation of Performance and Safety of Carbopol 980 NF 0.2%- Based Medical Device in the Management of Patients With Glaucomar or Ocular Hypertension and Concomitant Dry Eye Syndrome on Multiple Long-term Topical Hypotensive Therapy

Role: lead

NCT07431385Not ApplicableRecruiting

Performance and Safety of IRIDIUM GARZE in Blepharitis or Blepharconjunctivitis Adjuvant Treatment

Role: lead

NCT06922136Not ApplicableActive Not Recruiting

Evaluation of the Performance and Safety of Hyalo Gyn® Gel Compared to Placebo in Postmenopausal Breast Cancer Survivors

Role: lead

NCT06245603Not ApplicableRecruiting

A Study to Evaluate Efficacy and Safety of Hydeal Cyst® Intravesical Instillations in Patients Treated With Intravesical Chemotherapy or Immunotherapy in Non-muscle Invasive Bladder Cancer

Role: collaborator

NCT05024773Phase 3Recruiting

Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)

Role: lead

NCT05447767Not ApplicableActive Not Recruiting

Prediction AlgoriThm for regeneraTive Medicine Approach in knEe OA: New Decision-making Process Based on Patient pRofiliNg (PATTERN)

Role: collaborator

NCT06528600Not ApplicableCompleted

Comparative Study of Two Hyaluronic Acid Formulation in the Management of Knee Osteoarthritis

Role: lead

NCT06189456Not ApplicableUnknown

Evaluation of Performance and Safety of Eye Drops With Hyaluronic Acid 0.30% and 0.15%

Role: lead

NCT06113783Not ApplicableRecruiting

Assessment of Efficacy of a Single Intra-articular Injection of HYALUBRIX 60 in Knee Osteoarthritis

Role: lead

NCT06210373Not ApplicableUnknown

Assessment of Efficacy and Safety of the Use of Two Eye Gel Products Containing 5% Dexpanthenol in Patients With Moderate to Severe Dry Eye Syndrome

Role: lead

NCT06190054Not ApplicableUnknown

Evaluation of Performance and Safety of Eye Drops With Hydroxypropyl-methylcellulose and Inositol in Drye Eye Disease

Role: lead

NCT06108999Not ApplicableRecruiting

Management of Acute and Chronic Wounds With Hyaluronic Acid

Role: lead

NCT04975724Phase 4Unknown

Safety of Liposom With Citalopram in Elderly Patients With Major Depressive Disorder

Role: lead

NCT04585334Phase 4Unknown

Effectiveness of Tricortin 1000 in Patients Affected by Chronic Low Back Pain

Role: lead

NCT06103812Unknown

Evaluate Performance and Safety of Hyalo4 Skin in Acute and Chronic Wounds

Role: lead

NCT04358055Not ApplicableCompleted

Investigation to Evaluate the Clinical Safety and Effectiveness of WET® Gel

Role: lead

NCT04652752Not ApplicableTerminated

Clinical Investigation to Evaluate the Safety and Efficacy of Dressing CONNETTIVINA HI TECH in the Management of Superficial Cutaneous Lesions

Role: lead

NCT04936204Not ApplicableUnknown

Clinical Investigation to Evaluate the Safety and Performance of ConnettivinaBio Plus Cream Compared to ConnettivinaBio Cream in the Management of Wounds in Patients at High Risk of Infection

Role: lead

NCT04614415Not ApplicableUnknown

Clinical Investigation to Evaluate the Performance of Hyaluronic Acid for the Treatment of Hypertrophic Scars

Role: lead